Evaluation of the impact of 13-valent pneumococcal conjugate vaccine immunization in children by surveillance of culture-confirmed pneumococcal disease: a …
CH Chen, LH Su, HC Li, MH Hsu, TL Wu, CL Chen… - Vaccine, 2019 - Elsevier
The study aimed to investigate the impact of 13-valent pneumococcal conjugate vaccine
(PCV13) immunization on the overall pneumococcal disease in children in Taiwan by …
(PCV13) immunization on the overall pneumococcal disease in children in Taiwan by …
Impact of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease after introduction into routine pediatric use
R Baxter, L Aukes, SI Pelton, A Yee… - Journal of the …, 2021 - academic.oup.com
Abstract Background In 2010, the 13-valent pneumococcal conjugate vaccine (PCV13)
replaced 7-valent PCV (PCV7) for protection against invasive pneumococcal disease (IPD) …
replaced 7-valent PCV (PCV7) for protection against invasive pneumococcal disease (IPD) …
Redistribution of Streptococcus pneumoniae serotypes after Nationwide 13-valent pneumococcal conjugate vaccine program in children in northern Taiwan
YC Cho, NC Chiu, CY Lu, DTN Huang… - The Pediatric …, 2017 - journals.lww.com
Background: After the introduction of 13-valent pneumococcal conjugate vaccine (PCV13)
against Streptococcus pneumoniae, public health officials in Taiwan monitored a decline in …
against Streptococcus pneumoniae, public health officials in Taiwan monitored a decline in …
[HTML][HTML] Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan
Background Invasive pneumococcal disease (IPD) causes significant morbidity and
mortality, especially in children and older adults. Pneumococcal 7-valent and 13-valent …
mortality, especially in children and older adults. Pneumococcal 7-valent and 13-valent …
[HTML][HTML] Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
HY Lee, YC Hsieh, CC Liu, YC Huang… - Journal of microbiology …, 2018 - Elsevier
Abstract Background In Taiwan, the age group with the greatest incidence of invasive
pneumococcal disease is 2–5 years of age, which is different from other countries. This …
pneumococcal disease is 2–5 years of age, which is different from other countries. This …
Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta
Background: The seven-valent pneumococcal conjugate vaccine (PCV7) was licensed in
Canada in 2001. Routine infant vaccination programs in Alberta began in 2002. Several …
Canada in 2001. Routine infant vaccination programs in Alberta began in 2002. Several …
Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine
SL Kaplan, WJ Barson, PL Lin, JR Romero… - The Pediatric …, 2013 - journals.lww.com
Background: The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced for
routine administration to infants and children in 2010 in the United States. We have …
routine administration to infants and children in 2010 in the United States. We have …
Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
RA Gladstone, JM Jefferies, SN Faust… - Expert review of …, 2012 - Taylor & Francis
Pneumococcal disease remains a global problem despite the availability of effective
conjugate vaccines. The 13-valent pneumococcal conjugate vaccine (PCV13) extends the …
conjugate vaccines. The 13-valent pneumococcal conjugate vaccine (PCV13) extends the …
Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine
S Tomczyk, R Lynfield, W Schaffner… - Clinical Infectious …, 2016 - academic.oup.com
Background. Antibiotic-nonsusceptible invasive pneumococcal disease (IPD) decreased
substantially after the US introduction of the pediatric 7-valent pneumococcal conjugate …
substantially after the US introduction of the pediatric 7-valent pneumococcal conjugate …
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite …
MR Moore, R Link-Gelles, W Schaffner… - The Lancet Infectious …, 2015 - thelancet.com
Background In 2000, seven-valent pneumococcal conjugate vaccine (PCV7) was introduced
in the USA and resulted in dramatic reductions in invasive pneumococcal disease (IPD) and …
in the USA and resulted in dramatic reductions in invasive pneumococcal disease (IPD) and …